ASO Visual Abstract: Optimizing Circulating Tumor DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma—Diagnosis, Screening, Minimal Residual Disease Detection, and Treatment Response Monitoring

被引:0
|
作者
Woo Jin Choi
Tommy Ivanics
Annabel Gravely
Steven Gallinger
Gonzalo Sapisochin
Grainne M. O’Kane
机构
[1] University of Toronto,Department of Surgery
[2] University of Toronto,Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health
[3] University of Toronto Staff Surgeon,Division of General Surgery
[4] HBP and Multi Organ Transplant Program,Department of Surgery
[5] University Health Network,Department of Surgical Sciences
[6] Henry Ford Hospital,Department of Medical Oncology, Trinity St. James’s Cancer Institute
[7] Uppsala University,undefined
[8] Trinity College Dublin,undefined
[9] St. James’s Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3866 / 3867
页数:1
相关论文
共 22 条
  • [21] Detection of Early Molecular Response (EMR) and Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using a Validated Next Generation Sequencing (NGS) Assay for the Detection of Tumor Variants in Circulating Tumor (ct)DNA
    Stokowski, Renee P.
    Tabari, Ehsan
    Bogard, Patrick
    Hacker, Coleen
    Kameneva, Olga K.
    Ji, Tieming
    Teng, Li
    Melnikova, Vladislava
    McCord, Ron
    Punnoose, Elizabeth A.
    Loberg, Robert
    Shabbeer, Junaid
    BLOOD, 2022, 140 : 9257 - 9258
  • [22] MiRaDor: A proof-of- concept study of treatment efficacy by monitoring Minimal Residual Disease (MRD) using circulating tumor DNA (ctDNA) in hormone receptor-positive/HER2-negative (HR+/HER2-) early breast cancer (EBC)
    Llombart-Cussac, Antonio
    Perez-Garcia, Jose Manuel
    Gion, Maria
    Alcala-Lopez, Daniel
    Fazal-Salom, Janet
    Lazaris, Alexandros
    Mancino, Mario
    Shimizu, Eileen
    Victorino, Susana
    Zhang, Rui Rui
    Machackova, Zuzana
    Schimmoller, Frauke
    Wongchenko, Matthew
    Gligorov, Joseph
    Schmid, Peter
    Cortes, Javier
    CANCER RESEARCH, 2024, 84 (09)